While other aggregation-prone proteins, such as beta amyloid and tau, are cleared by the glymphatic system in models of Alzheimer’s disease and traumatic brain injury (66, –68), α-synuclein clearance by the system has yet to be determined. Here, MAPT is linked to Alzheimer disease.